Stocks · Health care · Medicinal Chemicals & Botanical Products

Glass House Brands Inc.

GLAS Clue Score41
United States Fiscal year ends December CIK 0001848731
$4.26 -3.40% Close, 9 Oct 2026

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
4.26 on 9 Oct 2026
13 9 4 Jun 2026 Aug 2026 Oct 2026 30 Jun 2026 $13.00 1 Jul 2026 $12.32 2 Jul 2026 $12.50 6 Jul 2026 $11.30 7 Jul 2026 $11.56 8 Jul 2026 $11.49 9 Jul 2026 $11.61 10 Jul 2026 $11.81 13 Jul 2026 $11.41 14 Jul 2026 $11.42 15 Jul 2026 $11.02 16 Jul 2026 $10.34 17 Jul 2026 $10.79 20 Jul 2026 $10.71 21 Jul 2026 $10.73 22 Jul 2026 $10.53 23 Jul 2026 $10.04 24 Jul 2026 $10.02 27 Jul 2026 $10.12 28 Jul 2026 $9.89 29 Jul 2026 $9.41 30 Jul 2026 $9.90 31 Jul 2026 $9.53 3 Aug 2026 $10.06 4 Aug 2026 $10.07 5 Aug 2026 $9.26 6 Aug 2026 $9.68 7 Aug 2026 $10.13 10 Aug 2026 $10.01 11 Aug 2026 $9.98 12 Aug 2026 $10.29 13 Aug 2026 $9.97 14 Aug 2026 $9.41 17 Aug 2026 $9.69 18 Aug 2026 $9.36 19 Aug 2026 $9.70 20 Aug 2026 $9.52 21 Aug 2026 $9.79 24 Aug 2026 $9.88 25 Aug 2026 $10.13 26 Aug 2026 $10.40 27 Aug 2026 $9.78 28 Aug 2026 $9.88 31 Aug 2026 $8.93 1 Sep 2026 $8.49 2 Sep 2026 $8.55 3 Sep 2026 $8.60 4 Sep 2026 $8.88 8 Sep 2026 $8.36 9 Sep 2026 $8.14 10 Sep 2026 $7.98 11 Sep 2026 $7.93 14 Sep 2026 $8.10 15 Sep 2026 $8.04 16 Sep 2026 $8.03 17 Sep 2026 $7.99 18 Sep 2026 $7.97 21 Sep 2026 $7.94 22 Sep 2026 $8.01 23 Sep 2026 $7.85 24 Sep 2026 $7.15 25 Sep 2026 $6.80 28 Sep 2026 $6.85 29 Sep 2026 $6.79 30 Sep 2026 $5.61 1 Oct 2026 $5.32 2 Oct 2026 $5.49 5 Oct 2026 $5.35 6 Oct 2026 $5.16 7 Oct 2026 $5.13 8 Oct 2026 $4.41 9 Oct 2026 $4.26 Tu William SVP, Corporate Controller Sold at will $30.66K 11 Sep 2026 · at $8.03 · 50.2% of stake
0 buys1 sale at will0 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$181.98M
Net income
$29.66M
Free cash flow
$15.73M
Gross margin
42.3%
Operating margin
-9.1%
Net margin
-16.3%
Return on equity
-40.1%
Return on capital
-9.2%
Debt to equity
0.93
Revenue growth, 1 yr
-9.4%
Revenue growth, 5 yr
30.4% a year

Revenue and profit

Fiscal years, as filed with the SEC · point at a year for the detail
Full statements →
48M -17M FY20 Fiscal year 2020 Revenue $48.26M Net income $16.66M Margin -34.5% 63M -43M FY21 Fiscal year 2021 Revenue $63.19M Net income $43.10M Margin -68.2% · growth +30.9% 85M -33M FY22 Fiscal year 2022 Revenue $84.87M Net income $32.90M Margin -38.8% · growth +34.3% 161M -98M FY23 Fiscal year 2023 Revenue $160.84M Net income $98.27M Margin -61.1% · growth +89.5% 201M 519K FY24 Fiscal year 2024 Revenue $200.90M Net income $519.00K Margin 0.3% · growth +24.9% 182M -30M FY25 Fiscal year 2025 Revenue $181.98M Net income $29.66M Margin -16.3% · growth -9.4%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
11 Sep 2026 Tu William
SVP, Corporate Controller
Sold at will $30.66K 50.2%
26 May 2026 Tu William
SVP, Corporate Controller
Sold at will $56.83K 100%
22 May 2026 Tu William
SVP, Corporate Controller
Sold at will $106.12K 65.8%
19 May 2026 Tu William
SVP, Corporate Controller
Sold at will $160.15K 45.9%